Cell and gene therapy venture capital and public funding deal count
Global, 2021 to 2023
96
2023
Cell and gene therapy venture capital and public funding deal count: Global, 2021 to 2023
Cell and gene therapy venture capital and public funding deal count: Global, 2021 to 2023. 3 observations from 2021 to 2023, ranging from 96 to 127. Latest value 96 (2023).
0
30
60
90
120
150
2021
2022
2023
127
96
Cell and gene therapy venture capital and public funding deal count: Global, 2021 to 2023
Cell and gene therapy venture capital and public funding deal count: Global, 2021 to 2023. 3 observations from 2021 to 2023, ranging from 96 to 127. Latest value 96 (2023).
0
50
100
150
2021
2022
2023
127
96
Cell and gene therapy venture capital and public funding deal count: Global, 2021 to 2023
Cell and gene therapy venture capital and public funding deal count: Global, 2021 to 2023. 3 observations from 2021 to 2023, ranging from 96 to 127. Latest value 96 (2023).
0
50
100
150
2021
2022
2023
127
96
View the underlying data
Cell and gene therapy venture capital and public funding deal count: Global, 2021 to 2023
Period
Type
Value
2021
Actual
127
2022
Actual
97
2023
Actual
96
Chart:
StatOrigin
· Source: IQVIA ·
statorigin.org
CC BY 4.0